Susquehanna International Group’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-6,389
| Closed | -$510K | – | 13677 |
|
|
2021
Q1 | $510K | Sell |
6,389
-901
| -12% | -$70.4K | ﹤0.01% | 9423 |
|
|
2020
Q4 | $575K | Buy |
7,290
+2,109
| +41% | +$124K | ﹤0.01% | 7979 |
|
|
2020
Q3 | $228K | Buy |
+5,181
| New | +$255K | ﹤0.01% | 9252 |
|
|
2020
Q2 | – | Sell |
-30,452
| Closed | -$1.14M | – | 11333 |
|
|
2020
Q1 | $1.09M | Buy |
30,452
+5,042
| +20% | +$287K | ﹤0.01% | 5199 |
|
|
2019
Q4 | $1.8M | Buy |
25,410
+20,014
| +371% | +$1.45M | ﹤0.01% | 4504 |
|
|
2019
Q3 | $404K | Buy |
+5,396
| New | +$457K | ﹤0.01% | 7730 |
|
|
2019
Q1 | – | Sell |
-37,727
| Closed | -$2.86M | – | 10254 |
|
|
2018
Q4 | $2.81M | Sell |
37,727
-54,084
| -59% | -$4.47M | ﹤0.01% | 3037 |
|
|
2018
Q3 | $8.45M | Sell |
91,811
-4,563
| -5% | -$435K | ﹤0.01% | 2113 |
|
|
2018
Q2 | $9.48M | Buy |
96,374
+57,763
| +150% | +$6.46M | ﹤0.01% | 1989 |
|
|
2018
Q1 | $4.3M | Buy |
38,611
+25,363
| +191% | +$2.84M | ﹤0.01% | 2729 |
|
|
2017
Q4 | $1.36M | Sell |
13,248
-11,536
| -47% | -$1.15M | ﹤0.01% | 4624 |
|
|
2017
Q3 | $2.33M | Sell |
24,784
-6,772
| -21% | -$534K | ﹤0.01% | 3630 |
|
|
2017
Q2 | $2.46M | Buy |
31,556
+18,616
| +144% | +$1.4M | ﹤0.01% | 3516 |
|
|
2017
Q1 | $1.04M | Sell |
12,940
-56,844
| -81% | -$4.52M | ﹤0.01% | 5054 |
|
|
2016
Q4 | $5.5M | Buy |
69,784
+57,223
| +456% | +$4.45M | ﹤0.01% | 2264 |
|
|
2016
Q3 | $980K | Sell |
12,561
-4,317
| -26% | -$313K | ﹤0.01% | 4839 |
|
|
2016
Q2 | $1.16M | Sell |
16,878
-31,270
| -65% | -$2.16M | ﹤0.01% | 4559 |
|
|
2016
Q1 | $3.44M | Buy |
48,148
+2,323
| +5% | +$146K | ﹤0.01% | 2844 |
|
|
2015
Q4 | $2.85M | Buy |
45,825
+22,025
| +93% | +$1.34M | ﹤0.01% | 3381 |
|
|
2015
Q3 | $1.35M | Buy |
23,800
+899
| +4% | +$47.6K | ﹤0.01% | 5078 |
|
|
2015
Q2 | $1.23M | Buy |
22,901
+5,601
| +32% | +$272K | ﹤0.01% | 5757 |
|
|
2015
Q1 | $822K | Sell |
17,300
-14,330
| -45% | -$634K | ﹤0.01% | 6146 |
|
|
2014
Q4 | $1.37M | Buy |
+31,630
| New | +$1.29M | ﹤0.01% | 5236 |
|
|
2014
Q3 | – | Sell |
-9,379
| Closed | -$343K | – | 10149 |
|
|
2014
Q2 | $343K | Buy |
+9,379
| New | +$318K | ﹤0.01% | 8147 |
|
|
2014
Q1 | – | Sell |
-17,158
| Closed | -$582K | – | 9618 |
|
|
2013
Q4 | $582K | Buy |
17,158
+5,741
| +50% | +$199K | ﹤0.01% | 6452 |
|
|
2013
Q3 | $364K | Sell |
11,417
-1,183
| -9% | -$31.5K | ﹤0.01% | 6924 |
|
|
2013
Q2 | $285K | Buy |
+12,600
| New | +$273K | ﹤0.01% | 6883 |
|
Susquehanna International Group's CMD Position: Q2 2021 in Review
Susquehanna International Group sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 6,389 shares — an estimated $510K sold.
Susquehanna International Group first reported a position in CMD in Q2 2013 and held it in 27 quarters. The position peaked at $9.48M in Q2 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Susquehanna International Group reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Susquehanna International Group sold 6,389 Cantel Medical Corporation shares in Q2 2021, an estimated $510K.
- Susquehanna International Group first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 27 quarters.
- Susquehanna International Group's Cantel Medical Corporation position peaked at $9.48M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.